This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB04172/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB04172/identifier/bindingdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB04172/identifier/pubchem-compound/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04172/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04172/identifier/drugbank/
n10http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04172
rdf:type
n9:Drug
n9:group
experimental
owl:sameAs
n6:DB04172 n8:DB04172
dcterms:title
[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine
adms:identifier
n4:46936909 n7:46507576 n12:DB04172 n13:UKP n14:23869
n9:IUPAC-Name
n10:271B4125-363D-11E5-9242-09173F13E4C5
n9:InChI
n10:271B412B-363D-11E5-9242-09173F13E4C5
n9:Molecular-Formula
n10:271B412A-363D-11E5-9242-09173F13E4C5
n9:Molecular-Weight
n10:271B4127-363D-11E5-9242-09173F13E4C5
n9:Monoisotopic-Weight
n10:271B4128-363D-11E5-9242-09173F13E4C5
n9:SMILES
n10:271B4129-363D-11E5-9242-09173F13E4C5
n9:Water-Solubility
n10:271B4123-363D-11E5-9242-09173F13E4C5
n9:logP
n10:271B4121-363D-11E5-9242-09173F13E4C5 n10:271B4124-363D-11E5-9242-09173F13E4C5
n9:logS
n10:271B4122-363D-11E5-9242-09173F13E4C5
n9:H-Bond-Acceptor-Count
n10:271B4131-363D-11E5-9242-09173F13E4C5
n9:H-Bond-Donor-Count
n10:271B4132-363D-11E5-9242-09173F13E4C5
n9:InChIKey
n10:271B412C-363D-11E5-9242-09173F13E4C5
n9:Polar-Surface-Area--PSA-
n10:271B412D-363D-11E5-9242-09173F13E4C5
n9:Polarizability
n10:271B412F-363D-11E5-9242-09173F13E4C5
n9:Refractivity
n10:271B412E-363D-11E5-9242-09173F13E4C5
n9:Rotatable-Bond-Count
n10:271B4130-363D-11E5-9242-09173F13E4C5
n9:Bioavailability
n10:271B4137-363D-11E5-9242-09173F13E4C5
n9:Ghose-Filter
n10:271B4139-363D-11E5-9242-09173F13E4C5
n9:MDDR-Like-Rule
n10:271B413A-363D-11E5-9242-09173F13E4C5
n9:Number-of-Rings
n10:271B4136-363D-11E5-9242-09173F13E4C5
n9:Physiological-Charge
n10:271B4135-363D-11E5-9242-09173F13E4C5
n9:Rule-of-Five
n10:271B4138-363D-11E5-9242-09173F13E4C5
n9:Traditional-IUPAC-Name
n10:271B4126-363D-11E5-9242-09173F13E4C5
n9:pKa--strongest-acidic-
n10:271B4133-363D-11E5-9242-09173F13E4C5
n9:pKa--strongest-basic-
n10:271B4134-363D-11E5-9242-09173F13E4C5